Skip to main content
Screener/Healthcare/Biotechnology

IKT — Inhibikase Therapeutics, Inc.

NASDAQ
$2.46+0.04 (+1.87%)
Micro CapPenny StockUnder $5Healthcare
$1.33
$2.53
$2.38
$2.48
EPS (TTM)$-0.54
P/E Ratio-3.83
Dividend Yield—
Market Cap$287.8M
Volume302K
Prev Close$2.41
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$16.4M$-0.17——
Q4 '25$0-$12.7M$-0.13——
Q3 '25$0-$11.9M$-0.13——
Q2 '25$0-$9.9M$-0.11——
Q1 '25$0-$13.7M$-0.15——
Q4 '24$0-$12.1M$-0.17——
Q3 '24$0-$5.8M$-0.65——
Q2 '24$0-$5.0M$-0.66——
Get Your Daily Market Recap